Profiel
Ernesto Aycardi worked as a Senior Director of Worldwide Clinical Research at Merck & Co., Inc. from 1998 to 2009.
He then worked as the Director of Medical Research at Biogen Canada, Inc. from 2009 to 2013.
In 2013, he became a Senior Director at EMD Serono, Inc. for a year.
From 2014 to 2018, he worked as the Vice President and Head of Clinical Trial Operations at Teva Pharmaceutical Industries Ltd.
In 2018, he became the Chief Medical Officer at Xenon Pharmaceuticals, Inc. Dr. Aycardi earned a doctorate degree from Universidad Nacional de Colombia.
Eerdere bekende functies van Ernesto Aycardi
| Bedrijven | Functie | Einde |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 23-04-2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01-01-2014 |
| Biogen Canada, Inc. | Chief Tech/Sci/R&D Officer | 01-01-2013 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01-01-2009 |
Opleiding van Ernesto Aycardi
| Universidad Nacional de Colombia | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Biogen Canada, Inc. |
